The healthcare technology company delivered the goods yet again with solid revenue growth.
News & Analysis: Cerner
CERN earnings call for the period ending September 30, 2019.
Cerner's products are meant to help the healthcare system operate more efficiently. Does exposure to strong long-term growth trends make Cerner's stock a buy?
Investors can expect Cerner to grow its top line by 6% to 9% over the next five years.
The healthcare technology provider met its revenue guidance and beat its adjusted earnings guidance, thanks primarily to growth in its services business.
CERN earnings call for the period ending June 30, 2019.
Both companies are digitizing healthcare, but one is executing better.
CERN earnings call for the period ending March 30, 2019.
The big healthcare-technology provider hit its first-quarter guidance thanks to solid professional services and managed services revenue growth.
The activist investment firm is pushing a program of change for the healthcare tech company.